The record
Written from the 1 report below. Nothing here is unsourced.
- Karnataka Food and Drug Administration officials cancelled or suspended 24 drug licences of retailers and wholesalers following the discovery of counterfeit medicine distribution.
- Pfizer India announced it is assisting investigators by providing technical information and removing affected product batches from the market.
- The enforcement action originated from a raid on an unlicensed facility in Bidadi that was relabeling low-cost drugs as expensive life-saving medications.
- The investigation into these operations is crucial for ensuring pharmaceutical supply chain integrity and public health safety.
What to watch next
- Outcome of the criminal case registered under the Drugs and Cosmetics Act
- Further regulatory actions against involved retailers and wholesalers
Who said what2
Only words found exactly in the article are shown, attributed and linked to the line they came from.
Pfizer India
2 quotes · 1 outlet
“Patient safety and product quality are of the highest priority for us at Pfizer”
In the article
…The Karnataka health regulator on Sunday said it has cancelled 16 drug licences of retailers and wholesalers and suspended eight others in connection with the alleged distribution and sale of spurious medicines. " Patient safety and product quality are of the highest priority for us at Pfizer ," the company said in a statement late on Tuesday evening. Pfizer India claimed that it has been working with authorities for the last one month since the matter was brought to its attention. "Since then, we have taken…
“Since then, we have taken several actions to support the investigation, including removing from the market Pfizer batches (where batch numbers were copied by counterfeit) to avoid confusion, supporting (efforts) to differentiate between original and counterfeit product, and providing technical and other relevant information related to the affected batches”
In the article
…priority for us at Pfizer," the company said in a statement late on Tuesday evening. Pfizer India claimed that it has been working with authorities for the last one month since the matter was brought to its attention. " Since then, we have taken several actions to support the investigation, including removing from the market Pfizer batches (where batch numbers were copied by counterfeit) to avoid confusion, supporting (efforts) to differentiate between original and counterfeit product, and providing technical and other relevant information related to the affected batches ," the company added. Pfizer stated that it continues to work closely with authorities to resolve the open queries, emphasising that its focus remains on protecting patients, safeguarding public health and maintaining…
Coverage1
All filed from India
Named India · Pfizer India · Bengaluru South · Bidadi · Karnataka Food and Drug Administration · Kurubarakeranahalli
The 1 report is listed beside the record.
Ask this story
Answers cite the reports above, or say they can't.